Aug 5, 2026 04:05PM
May 11, 2026 08:30AM
May 11, 2026 08:30AM
May 11, 2026 08:30AM
Sep 22, 2025 09:03AM
Aug 25, 2025 08:01AM
Aug 25, 2025 08:00AM Evolus Announces Positive Data From Pivotal Trial for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product at 2025 Cosmetic Bootcamp
Aug 20, 2025 08:01AM
Aug 20, 2025 08:00AM
Jul 31, 2025 08:06AM
Jul 31, 2025 08:05AM
Jun 10, 2025 08:00AM
Apr 17, 2025 05:38AM
Mar 4, 2025 04:05PM Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance
Feb 13, 2025 01:32PM
Feb 13, 2025 01:30PM
Jan 21, 2025 08:04AM
Jan 21, 2025 08:00AM
Nov 6, 2024 04:05PM
Oct 29, 2024 08:00AM
Jul 31, 2024 04:05PM Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance
Jun 24, 2024 08:00AM
Jun 24, 2024 08:00AM
May 20, 2024 08:31AM
May 20, 2024 08:30AM
May 7, 2024 04:05PM
Apr 17, 2024 04:06PM
Apr 17, 2024 04:05PM Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
Mar 7, 2024 04:05PM
Mar 1, 2024 08:31AM
Mar 1, 2024 08:30AM
Jan 16, 2024 05:36PM
Jan 16, 2024 05:28PM
Nov 6, 2023 08:51AM
Nov 6, 2023 08:45AM “Extra-Strength” 40U Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Phase II Data Presented at 2023 ASDS Annual Meeting
Aug 8, 2023 08:46AM
Aug 8, 2023 08:45AM
Jun 22, 2023 08:46AM
Jun 22, 2023 08:45AM
Jun 8, 2023 04:05PM
Jan 29, 2023 06:34PM
Jan 28, 2023 08:00AM "Extra-Strength" Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Interim Phase II Data Results, Representing Prolonged 6-Month Performance
Jan 23, 2023 08:00AM
Aug 24, 2022 08:15AM
Aug 24, 2022 08:14AM
Jul 19, 2022 08:37AM
Jul 12, 2022 08:47AM
Jun 2, 2022 08:55AM
Jun 2, 2022 08:54AM Peer-Reviewed Post Hoc Analysis Shows Jeuveau® is Highly Effective for Millennials by All Measures and at All Time Points Assessed
May 18, 2022 08:15AM

328,141 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All